Bearishness Around Pfizer Gilead Sparks Opportunity
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Explore when to make changes to your spending plan and how to rebalance categories so you stay aligned with goals and cash flow.
23,566 articlesWall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Bitcoin opened lower at the market open as traders weigh fresh claims against Jane Street and evolving ETF liquidity....
A January 12, 2026 bill aims to ban lawmakers and families from buying stocks, with public notice and hefty penalties...
In healthcare robotics, durable moats matter as much as dazzling tech. This article breaks down why intuitive surgica...
Two key on-chain signals—Coinbase Premium and Exchange Netflows—may lead Bitcoin moves as Warsh takes the helm and li...
A GOP lawmaker is proposing language to widen a congressional stock ban bill to cover prediction markets like Kalshi ...
NAR’s board maintained 2027 dues at $156 per member and kicked a proposed ethics Standard of Practice back to committ...
Markets are digesting a potential shift in Fed communication as Kevin Warsh signals a move away from scripted guidanc...
Pi Network's core team has set a July 22 deadline for Protocol v25, signaling a push to stabilize the ecosystem amid ...
The FTC and 11 states reached a $100 million settlement with Walmart over alleged wage and tip-disclosure violations ...
The Montana Supreme Court delivered a unanimous ruling this week, preserving the 2023 housing reform package aimed at...
Sagent rolled out AI-enabled updates to the Dara platform at Ignite, signaling a shift toward AI-driven mortgage serv...